TITLE

Drug Cloud

PUB. DATE
July 2000
SOURCE
Technology Review;Jul/Aug2000, Vol. 103 Issue 4, p20
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Informs that Battelle Pulmonary Therapeutics is aiming to deliver inhalable drugs more efficiently with `electrohydrodynamic' or EHD, aerosol technology. Use of voltage, rather than pressure, to create a `soft cloud' of aerosolized drug; Valuable against respiratory diseases and infections.
ACCESSION #
3230313

 

Related Articles

  • aerosols.  // Royal Society of Medicine: Medicines;2002, p40 

    This article provides information on the term aerosols. These are a means of administering drugs as fine droplets in a spray, often from a nebulizer.

  • inhalation therapy.  // Taber's Cyclopedic Medical Dictionary (2009);2009, Issue 21, p1195 

    A definition of the term "inhalation therapy" is presented.

  • Stop Repeat Sinus Infections. Harrar, SarĂ­; Glabman, Maureen // Prevention;Nov2003, Vol. 55 Issue 11, p52 

    Evaluates the SinuNEB nebulizer, which, according to one U.S. study, kept chronic sinusitis sufferers infection-free for an average of 17 weeks. Side effects that come with oral or intravenous antibiotics; Considerations before using SinuNEB; Machine size.

  • Literature Reviews: Allergy and Immunology. Lampe, John B.; Melton Jr, A. L. // Clinical Pediatrics;Jan2000, Vol. 39 Issue 1, p61 

    Presents a summary of the article `Inhalation Therapy in Asthma: Nebulizer or Pressurized MDI With Holding Chamber? In Vivo Comparison of Lung Deposition in Children,' by J.H. Wildhaber, N.D. Dore, J.M. Wilson, et al., published in a 1999 issue of `Journal of Pediatrics.'

  • Production of nanoaerosols of sparingly water-soluble drugs: The effect of indomethacin nanoparticles. Onishchuk, A. A.; Tolstikova, T. G.; Sorokina, I. V.; Baklanov, A. M.; Karasev, V. V.; Boldyrev, V. V.; Fomin, V. M. // Doklady Biochemistry & Biophysics;Apr2009, Vol. 425 Issue 1, p106 

    The article presents a study on the production of nanoaerosols of sparingly water-soluble drugs. It develops an inhaler based on a thermal condensation-type that generates nanoparticles of drugs at a high concentration with a high stability. The anti-inflammatory properties of indomethacin was...

  • Nebuliser therapy.  // Nursing Standard;4/6/2011, Vol. 25 Issue 31, p58 

    A quiz concerning nebuliser therapy is presented.

  • BATTELLE SIGNS RESEARCH AGREEMENT WITH EIFFEL TECHNOLOGIES.  // Worldwide Biotech;Feb2002, Vol. 14 Issue 2, p6 

    Focuses on the research agreement between Battelle Pulmonary Therapeutics Inc. and Eiffel Research & Development Pty. Ltd. on electrohydrodynamic and pulmonary delivery device.

  • Pfizer, Battelle Join Up.  // Chemical Market Reporter;09/25/2000, Vol. 258 Issue 13, p52 

    Deals with the agreement between Pfizer Inc. and Battelle Pulmonary Therapeutics to develop drug products to treat pulmonary and systematic diseases. Terms of the agreement.

  • Prolastin aerosol therapy and sputum taurine in cystic fibrois. Cantin, AndrĂ© M.; Berthiaume, Yves; Cloutier, Diane; Martel, Marc // Clinical & Investigative Medicine;Aug2006, Vol. 29 Issue 4, p201 

    The article discusses the effects of Prolastin aerosol therapy on airway inflammation in cystic fibrosis. Prolastin is a therapeutic preparation of alpha-1 proteinase inhibitor, a neutrophil elastase inhibitor. It also presents a conclusion that aerosol therapy with Prolastin in patients with...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics